(19)
(11) EP 4 816 050 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898695.2

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61N 1/36(2006.01)
A61B 5/00(2006.01)
A61N 1/05(2006.01)
A61B 5/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/36053; A61N 1/36139; A61N 1/36096; A61N 1/36064; A61N 1/36082; A61N 1/36132; A61N 1/3615
(86) International application number:
PCT/US2024/057600
(87) International publication number:
WO 2025/117633 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605030 P

(71) Applicant: Iveacare, Inc.
Roseville, Minnesota 55113 (US)

(72) Inventors:
  • LIBBUS, Imad
    St. Paul, Minnesota 55105 (US)
  • KERKOW, Todd Alan
    Stacy, Minnesota 55079 (US)

(74) Representative: Grassi, Stefano 
Bugnion S.p.A. Viale Lancetti, 17
20158 Milano
20158 Milano (IT)

   


(54) COORDINATED NEUROSTIMULATION FOR EPILEPSY AND DEPRESSION TREATMENT